Author

Mohamad Aljofan

Nazarbayev University - Cited by 1,600 - Pharmacology

Biography

Dr.Mohamad Aljofan is currently an assistant professor at Monash University, School of Medicine and Health Sciences. He is particularly interested in the research areas of antiviral development and viral immune evasion. During the past six years he has been conducting research into the recently emerged Hendra and Nipah viruses, both novel zoonotic agents with no effective therapeutics. Their classification as Biological Safety Level 4 (BSL4) pathogens, and their inclusion as National Institute of Allergy and Infectious Diseases (NIAID) Category C priority pathogens make novel antiviral drug development a high priority and this has been the core of his recent research.
Title
Cited by
Year
Anticancer activity of metformin: a systematic review of the literature
M Aljofan, D RiethmacherFuture Science OA 5 (8), FSO410, 2019201
105
2019
An overview of drug discovery and development
N Berdigaliyev, M AljofanFuture medicinal chemistry 12 (10), 939-947, 2020202
104
2020
Comparison of different serum sample extraction methods and their suitability for mass spectrometry analysis
TM Alshammari, AA Al-Hassan, TB Hadda, M AljofanSaudi pharmaceutical journal 23 (6), 689-697, 2015201
57
2015
Prevalence of use and reported side effects of herbal medicine among adults in Saudi Arabia
SI Alkhamaiseh, M AljofanComplementary Therapies in Medicine 48, 102255, 2020202
45
2020
Knowledge, attitude, and practice toward COVID-19 vaccination in Kazakhstan: a cross-sectional study
A Issanov, Z Akhmetzhanova, D Riethmacher, M AljofanHuman vaccines & immunotherapeutics 17 (10), 3394-3400, 2021202
38
2021
Prevalence and factors influencing use of herbal medicines during pregnancy in Hail, Saudi Arabia: a cross-sectional study
M Aljofan, S AlkhamaisehSultan Qaboos University Medical Journal 20 (1), e71, 2020202
35
2020
Clinical evidences on the antiviral properties of macrolide antibiotics in the COVID-19 era and beyond
D Poddighe, M AljofanAntiviral Chemistry and Chemotherapy 28, 2040206620961712, 2020202
34
2020
Anti-hepatitis B activity of isoquinoline alkaloids of plant origin
M Aljofan, HJ Netter, AN Aljarbou, TB Hadda, IE Orhan, B Sener, ...Archives of virology 159, 1119-1128, 2014201
33
2014
Cardioprotective effect of grape polyphenol extract against doxorubicin induced cardiotoxicity
S Sergazy, Z Shulgau, G Fedotovskikh, L Chulenbayeva, A Nurgozhina, ...Scientific Reports 10 (1), 14720, 2020202
31
2020
COVID-19 treatment: the race against time
M Aljofan, A GaipovMODESTUM LTD, 2020202
29
2020
Public knowledge, attitude and practice toward diabetes mellitus in Hail region, Saudi Arabia
M Aljofan, A Altebainawi, MN AlrashidiInternational Journal of General Medicine, 5-262, 2019201
25
2019
The potential role of extracellular vesicles in COVID-19 treatment: opportunity and challenge
Y Yan, W Zhou, Y Wang, Q Guo, F Zhao, Z Zhu, Y Xing, H Zhang, ...Frontiers in molecular biosciences 8, 699929, 2021202
22
2021
Pharmacy Malpractice: The rate and prevalence of dispensing high-risk prescription-only medications at community pharmacies in Saudi Arabia
TM Alshammari, SA Alhindi, AM Alrashdi, I Benmerzouga, M AljofanSaudi pharmaceutical journal 25 (5), 709-714, 2017201
21
2017
Chloroquine and COVID-19: A Light at the End of the Tunnel, or is it Another Train?
M Aljofan, A GaipovMODESTUM LTD,
20
2020
Current advances in the utilization of nanotechnology for the diagnosis and treatment of diabetes
VR Devadasu, TM Alshammari, M AljofanInternational Journal of Diabetes in Developing Countries 38 (1), 11-19, 2018201
17
2018
POM analyses of Raltegravir derivatives: A new reflection enlightening the mechanism of HIV-integrase inhibition
S Lahsasni, T Ben Hadda, V Masand, NB Pathan, A Parvez, I Warad, ...Research on Chemical Intermediates 41, 5121-5136, 2015201
16
2015
Epidemiology of dialysis-treated end-stage renal disease patients in Kazakhstan: data from nationwide large-scale registry 2014–2018
A Gaipov, A Issanov, K Kadyrzhanuly, D Galiyeva, M Khvan, M Aljofan, ...BMC nephrology 21, 1-9, 2020202
16
2020
Vaccine adherence: the rate of hesitancy toward childhood immunization in Kazakhstan
Z Akhmetzhanova, V Sazonov, D Riethmacher, M AljofanExpert review of vaccines 19 (6), 579-584, 2020202
15
2020
COVID-19 outbreak in post-soviet states: modeling the best and worst possible scenarios
A Issanov, Y Amanbek, A Abbay, S Adambekov, M Aljofan, ...medRxiv, 2020.04. 19.20071704, 2020202
14
2020
Practices of patients consuming antibiotics and knowledge about antibiotic resistance in Hail region–Saudi Arabia
I Benmerzouga, SA Al-Zammay, MM Al-Shammari, SA Alsaif, TM Alhaidan, ...Future Science OA 5 (10), FSO420, 2019201
12
2019

Referred From: https://scholar.google.com/citations?user=cETdEGAAAAAJ&hl=en

Cited by
Citations 1600
h-index 24
i10-index 35
Recommended Journals
Open Access Journals